Evaluation of efficiency of screening extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent

K. Lee, J. K. Lim, D. Yong, J. Yum, Y. Chong, R. Okamoto, M. Inoue

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The disk screening methods for extended-spectrum β-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to ≤20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime, and ceftazidime-clavulanic acid disks are stable at -20°C for 12 weeks.

Original languageEnglish
Pages (from-to)3696-3699
Number of pages4
JournalJournal of Clinical Microbiology
Volume39
Issue number10
DOIs
Publication statusPublished - 2001 Oct 22

Fingerprint

Ceftazidime
Cefotaxime
cefpodoxime
Klebsiella pneumoniae
Escherichia coli
Bacteria
Cefoxitin
Clavulanic Acid

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)

Cite this

@article{189d59b832a74e9f9a3a7646a2754b29,
title = "Evaluation of efficiency of screening extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent",
abstract = "The disk screening methods for extended-spectrum β-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to ≤20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime, and ceftazidime-clavulanic acid disks are stable at -20°C for 12 weeks.",
author = "K. Lee and Lim, {J. K.} and D. Yong and J. Yum and Y. Chong and R. Okamoto and M. Inoue",
year = "2001",
month = "10",
day = "22",
doi = "10.1128/JCM.39.10.3696-3699.2001",
language = "English",
volume = "39",
pages = "3696--3699",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "10",

}

Evaluation of efficiency of screening extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent. / Lee, K.; Lim, J. K.; Yong, D.; Yum, J.; Chong, Y.; Okamoto, R.; Inoue, M.

In: Journal of Clinical Microbiology, Vol. 39, No. 10, 22.10.2001, p. 3696-3699.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of efficiency of screening extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent

AU - Lee, K.

AU - Lim, J. K.

AU - Yong, D.

AU - Yum, J.

AU - Chong, Y.

AU - Okamoto, R.

AU - Inoue, M.

PY - 2001/10/22

Y1 - 2001/10/22

N2 - The disk screening methods for extended-spectrum β-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to ≤20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime, and ceftazidime-clavulanic acid disks are stable at -20°C for 12 weeks.

AB - The disk screening methods for extended-spectrum β-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to ≤20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime, and ceftazidime-clavulanic acid disks are stable at -20°C for 12 weeks.

UR - http://www.scopus.com/inward/record.url?scp=0034787683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034787683&partnerID=8YFLogxK

U2 - 10.1128/JCM.39.10.3696-3699.2001

DO - 10.1128/JCM.39.10.3696-3699.2001

M3 - Article

C2 - 11574594

AN - SCOPUS:0034787683

VL - 39

SP - 3696

EP - 3699

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 10

ER -